Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9385876 | Respiratory Medicine | 2005 | 11 Pages |
Abstract
There are readily identifiable risk factors for ambulatory treatment failure of exacerbations of CB and COPD. In addition, long-term oxygen therapy and short-acting beta-2 agonists are associated with late recovery, and the use of moxifloxacin compared with co-amoxiclav and clarithromycin is associated with faster recovery of symptoms.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Marc Miravitlles, Carles Llor, Karlos Naberan, Josep MarÃa Cots, Jesús Molina, for the EFEMAP study group for the EFEMAP study group,